Skip to content

Altimmune ALT Change in Other Assets

Change in Other Assets at other companies

Eli Lilly logo
Eli LillyLLY
$1.65B+98.4%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$40.65M+330%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$4.63M-148%
Wave Life Sciences logo
Wave Life SciencesWVE
$751K+736%
Delcath Systems logo
Delcath SystemsDCTH
$423K-70.2%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$1.28M

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's change in other assets?
Altimmune (ALT) reported change in other assets of -$1.62M in Q1 2026.
How has Altimmune's change in other assets changed year-over-year?
Altimmune's change in other assets decreased by 477.8% year-over-year, from $428K to -$1.62M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.